Yurpeak Cost in India: Weekly & Monthly Pricing (2026)

Yurpeak Injection Updated Pricing in India (2026)

If you’re looking into Yurpeak injections for weight loss or diabetes, your first and most obvious question is: What is the Yurpeak cost in India?

Officially launched in India in December 2025, Yurpeak (tirzepatide) by Cipla in partnership with Eli Lilly, is the newest and most accessible brand of tirzepatide now available across the country. It contains the exact same active molecule as Mounjaro, is manufactured by Eli Lilly and is distributed through Cipla’s wide pharmacy network.

Yurpeak cost in India starts at ₹13,125 per month for the 2.5 mg dose, going up to ₹25,781 per month for the higher 15 mg dose. It is available exclusively as a KwikPen (prefilled injector pen) in six dose strengths. There are no vial options for Yurpeak, only the convenient KwikPen format.

What Is Yurpeak?

Yurpeak is the second brand of tirzepatide in India, launched by Cipla Limited under an exclusive distribution and promotion agreement with Eli Lilly. As per Cipla’s official press release, Eli Lilly continues to manufacture and supply the drug, while Cipla handles marketing and distribution, especially in tier-2 and tier-3 cities across India.

Tirzepatide is the world’s first dual GIP and GLP-1 receptor agonist, meaning it activates two hormone pathways simultaneously, something no other injectable weight loss medication currently does. This dual mechanism makes it exceptionally effective for both blood sugar management and substantial weight loss.

Yurpeak is indicated for:

• Adults with Type 2 Diabetes Mellitus requiring better glycaemic control
• Chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related health condition

Yurpeak KwikPen Dose-Wise Prices in India

Yurpeak is available exclusively in the KwikPen format, a multi-dose, single-patient-use prefilled pen. Each pen contains four fixed weekly doses, making one pen equal to a full month’s supply.

The six available dose strengths and their prices in India are:

• 2.5 mg KwikPen: ₹13,125 per month
• 5 mg KwikPen: ₹16,406 per month
• 7.5 mg KwikPen: ₹20,625 per month
• 10 mg KwikPen: ₹20,625 per month
• 12.5 mg KwikPen: ₹25,781 per month
• 15 mg KwikPen: ₹25,781 per month

Yurpeak KwikPen Monthly Cost (All Doses):

Please Note: Yurpeak does not come in single-dose vials. If you prefer vials, Mounjaro vials are available for the 2.5 mg and 5 mg strengths. Both Yurpeak and Mounjaro contain the same active ingredient (tirzepatide) at the same price.

Yurpeak Dosing: How It Is Started and Escalated

Your doctor will almost always start you on the 2.5 mg dose as an initiation dose. This is not meant for long-term blood sugar management; it is simply to help your body adjust to the medicine.

The standard dose escalation protocol is:

1. Weeks 1-4: 2.5 mg once weekly
2. Weeks 5-8: 5 mg once weekly
3. Weeks 9-12: 7.5 mg (if needed)
4. Weeks 13-16: 10 mg (if needed)
5. Weeks 17-20: 12.5 mg (if needed)
6. Week 21 onwards: 15 mg (maximum dose, if needed)

Most patients achieve excellent results between 5 mg and 10 mg without needing to escalate to the highest doses. Your treating physician will decide the ideal dose based on your response, tolerability and goals.

Yurpeak Weight Loss Programme at Dr. Rajat Goel’s Clinic

Weight loss is not just about the injection; it requires a complete, medically supervised approach. At Dr. Rajat Goel’s clinic, patients starting Yurpeak or Mounjaro (tirzepatide) receive a comprehensive, personalised programme that includes:

• Dietetics Support: Customised meal plans and nutrition guidance tailored to your lifestyle, food preferences and health goals
• Weekly Group Consultations: Motivational group sessions where patients share progress, troubleshoot side effects and receive expert guidance
• Medical Supervision: Regular monitoring under Dr. Rajat Goel’s guidance to ensure safety, adjust dosing and track outcomes
• Lifestyle Coaching: Practical support for incorporating physical activity and sustainable habits into your daily routine

The right combination of medication, nutrition and professional support can help you lose significantly more weight than medication alone.

Start your journey today with our Tirzepatide Weight Loss Programme.

Yurpeak vs Mounjaro: What Is the Difference?

This is one of the most common questions patients ask. The short answer: they are the same drug, made by the same company, at the same price. But there are a few practical differences worth knowing.

As reported by Reuters, Eli Lilly signed this partnership with Cipla specifically to expand tirzepatide access beyond metro cities into semi-urban and rural India, leveraging Cipla’s network of over 1,50,000 pharmacy and retail outlets nationwide.

The key practical difference: Yurpeak is KwikPen only. If you prefer the flexibility of individual vial doses (useful if you’re on a lower dose and want more cost control), Mounjaro vials are the better choice. But if convenience and wide availability are your priorities, Yurpeak KwikPen is an equally excellent option.

For a detailed comparison of these injectable therapies, you can also read our article on Mounjaro vs Wegovy in India.

Yurpeak vs Wegovy vs Ozempic: Price Comparison

If you are evaluating all available weight loss injections in India, here is how Yurpeak compares on monthly cost:

Yurpeak (tirzepatide) may cost slightly more at higher doses compared to Ozempic, but clinical trials have shown that tirzepatide delivers significantly greater weight loss: up to ~23% body weight reduction compared to around 12-15% with semaglutide (Wegovy/Ozempic), making it a stronger option when maximum results are the goal.

For detailed pricing on these alternatives, read:

• Ozempic Cost in India
• Wegovy Cost in India

What Is Included in the Yurpeak Price?

When you purchase a Yurpeak KwikPen, here is what you receive:

• A single prefilled KwikPen containing four fixed weekly doses (one month’s supply)
• The pen is designed for subcutaneous injection in the abdomen, thigh, or upper arm
• Each pen is a single-patient device, not to be shared
• The medication requires cold chain storage (2°C-8°C) and is typically refrigerated during delivery by licensed pharmacies
• Once removed from the refrigerator, the pen can be kept at room temperature for up to 21 days

Cold chain shipping costs may or may not be included depending on the pharmacy and city of delivery. Always purchase from a licensed pharmacy with a valid prescription.

Common Side Effects of Yurpeak (Tirzepatide)

Like all medications, Yurpeak can cause side effects, particularly during the initial weeks. The most common ones include:

Common (usually mild and temporary):

• Nausea
• Diarrhoea or constipation
• Vomiting
• Stomach pain or bloating
• Indigestion (dyspepsia)
• Reduced appetite

Serious (seek medical attention immediately):

• Signs of pancreatitis (severe abdominal pain)
• Symptoms of low blood sugar (hypoglycaemia) if taken with insulin
• Changes in vision (diabetic retinopathy complications)
• Signs of allergic reaction
• Symptoms of thyroid problems (neck lump, hoarseness, difficulty swallowing)

Yurpeak should not be used by patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2).

Starting on the lowest dose (2.5 mg) and gradually escalating helps most patients manage side effects comfortably. Eating smaller meals, staying well hydrated and avoiding fatty or spicy food can help minimise nausea.

Who Should Not Use Yurpeak?

Yurpeak is not suitable for:

• Patients with a personal or family history of medullary thyroid carcinoma (MTC)
• Patients with Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
• Individuals under 18 years of age
• Pregnant women or women planning pregnancy
• Breastfeeding mothers
• Patients with Type 1 Diabetes
• Patients with severe gastrointestinal disorders or history of pancreatitis

Always inform your doctor about all medications and health conditions before starting Yurpeak.

Where to Buy Yurpeak in India?

Yurpeak is available only on a valid doctor’s prescription. You can access it through:

• Licensed endocrinologists, diabetologists and bariatric physicians
• Major hospital pharmacies across India
• Trusted online pharmacies (1mg, Apollo Pharmacy, PharmEasy) with cold chain delivery
• Cipla-affiliated pharmacies across metro, tier-2 and tier-3 cities
• Dr. Rajat Goel’s clinic for patients enrolled in the Tirzepatide Weight Loss Programme

Cipla’s primary focus with Yurpeak is to make tirzepatide accessible beyond metro cities, so even if you are in a smaller city or town, availability should be significantly better compared to Mounjaro. However, always insist on a sealed, original pen device and check for proper cold storage during delivery.

Will Yurpeak’s Price Come Down in the Future?

Yes, very likely. Yurpeak is currently protected under Eli Lilly’s patent on tirzepatide. Once the patent expires (estimated around 2027–2028), Indian generic pharmaceutical companies may be able to manufacture their own versions of tirzepatide, potentially bringing prices down by 50-70%, similar to what is expected with semaglutide generics.

Additionally, as Cipla scales up its distribution and competition between brands grows, we may see market-driven price corrections and discount offers from pharmacies and online platforms even before patent expiry.

Is Yurpeak Worth the Cost?

Tirzepatide, also sold as Mounjaro or Yurpeak is the most effective approved weight loss injection available in India today. Clinical evidence shows it can help patients lose up to 20-23% of their body weight when combined with a healthy diet and exercise. For patients with Type 2 Diabetes, it also delivers superior HbA1c reduction compared to many older treatments.

At ₹13,125/month for the starting dose, it is comparable in cost to Mounjaro, slightly costlier than Ozempic, but arguably delivers better results. For patients in tier-2 and tier-3 cities, Yurpeak is likely to be more easily accessible than Mounjaro, making it an excellent option for a wider population.

That said, Yurpeak is a prescription-only, medically supervised therapy. It is not a casual supplement or over-the-counter slimming aid. It must be started and managed under the guidance of a qualified physician.

If you’re considering Yurpeak for weight management or diabetes control, book a consultation with Dr. Rajat Goel to get personalised dosage planning, diet support and lifestyle guidance.

Frequently Asked Questions

1. What is the cost of Yurpeak in India?
   Yurpeak costs ₹13,125 per month for the 2.5 mg starting dose and goes up to ₹25,781 per month for the 15 mg dose. All prices are for the KwikPen format containing four weekly doses.
2. Is Yurpeak the same as Mounjaro?
   Yes. Both Yurpeak and Mounjaro contain the same active ingredient i.e tirzepatide and are manufactured by Eli Lilly at the same price. The only differences are the brand name, the distribution company (Cipla for Yurpeak, Eli Lilly for Mounjaro) and the fact that Yurpeak is available only as a KwikPen (no vials).
3. Is Yurpeak available without a prescription?
   No. Yurpeak is a prescription-only medication. A valid doctor’s prescription is mandatory to purchase it from any licensed pharmacy.
4. What is the price of Yurpeak 2.5 mg KwikPen?
   The Yurpeak 2.5 mg KwikPen (4 weekly doses = 1 month supply) is priced at ₹13,125. This is the starting/initiation dose.
5. Which is cheaper: Yurpeak or Wegovy?
   At the starting dose, Wegovy (₹10,850/month) is slightly cheaper than Yurpeak (₹13,125/month). However, at higher maintenance doses, prices become comparable. Tirzepatide (Yurpeak/Mounjaro) generally delivers greater weight loss than semaglutide (Wegovy/Ozempic) based on clinical trial data.
6. Can I switch from Mounjaro to Yurpeak?
   Since they contain the exact same molecule at the same dose, switching should be medically straightforward. Consult your doctor before making any changes to your prescription.
7. How many doses are in one Yurpeak KwikPen?
   Each Yurpeak KwikPen contains four fixed weekly doses, covering one full month of treatment.
8. Is Yurpeak available in small towns and cities?
   Yes. Cipla’s distribution network covers over 1,50,000 pharmacy and retail outlets including tier-2 and tier-3 cities, making Yurpeak significantly more accessible than Mounjaro in non-metro areas.
9. Is Yurpeak safe for long-term use?
   Tirzepatide has strong clinical safety data for use in adults with Type 2 Diabetes and obesity. However, long-term use must always be monitored by a qualified physician. Do not self-medicate.
10. How does Yurpeak help in weight loss?
    Yurpeak contains tirzepatide, which activates both GIP and GLP-1 receptors, making you feel full faster, reducing appetite, slowing stomach emptying and improving insulin sensitivity. This dual action results in significant and sustained weight loss when combined with a healthy diet and regular physical activity.

Also Read: Mounjaro vs Ozempic: Which Weight Loss Drug Works Best?
How to Use Mounjaro KwikPen (Step-by-Step)

If you’re considering Yurpeak for weight management or Type 2 Diabetes, speak to a specialist before starting. Book a consultation with Dr. Rajat Goel for expert medical guidance, personalised dosage plans and complete support throughout your treatment journey.